IR-Med, Inc. Terminates Material Agreement
Ticker: IRME · Form: 8-K · Filed: Oct 17, 2024 · CIK: 1839133
| Field | Detail |
|---|---|
| Company | Ir-Med, Inc. (IRME) |
| Form Type | 8-K |
| Filed Date | Oct 17, 2024 |
| Risk Level | medium |
| Pages | 1 |
| Reading Time | 2 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: agreement-termination, material-event
TL;DR
IR-Med just terminated a big deal they made 2 days ago. WTF?
AI Summary
IR-Med, Inc. announced on October 17, 2024, the termination of a material definitive agreement that was originally entered into on October 15, 2024. The filing does not specify the other party to the agreement or the nature of the agreement.
Why It Matters
The termination of a material definitive agreement can significantly impact a company's operations, strategic direction, and financial performance.
Risk Assessment
Risk Level: medium — Termination of a material agreement, especially one entered into so recently, suggests potential issues or a change in strategic direction that could affect the company's future.
Key Players & Entities
- IR-Med, Inc. (company) — The company filing the report.
- October 17, 2024 (date) — Date of the report.
- October 15, 2024 (date) — Date of the earliest event reported (termination of agreement).
FAQ
What was the material definitive agreement that was terminated?
The filing does not specify the nature or details of the material definitive agreement that was terminated.
Who was the other party to the terminated agreement?
The filing does not disclose the identity of the other party involved in the terminated agreement.
What is the reason for the termination of the agreement?
The filing does not provide any explanation or reason for the termination of the material definitive agreement.
When was the agreement originally entered into?
The agreement was entered into on October 15, 2024.
What is the potential financial impact of this termination on IR-Med, Inc.?
The filing does not provide any information regarding the financial impact of the agreement's termination on IR-Med, Inc.
Filing Stats: 404 words · 2 min read · ~1 pages · Grade level 13.8 · Accepted 2024-10-17 16:05:18
Filing Documents
- form8-k.htm (8-K) — 34KB
- 0001493152-24-041406.txt ( ) — 198KB
- irme-20241017.xsd (EX-101.SCH) — 3KB
- irme-20241017_lab.xml (EX-101.LAB) — 33KB
- irme-20241017_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IR-Med, Inc. By: /s/ Sharon Lefkoviz Name: Sharon Lefkoviz Title: Chief Financial Officer Date: October 17, 2024